Companies

Polaryx Therapeutics, Inc. (PLYX) SEC filings

CIK 0002075320 · Pharmaceutical Preparations (SIC 2834) · Nasdaq · incorporated in WY · fiscal year ends 12/31

Annual financials (from the company's own XBRL in its 10-K filings)

FY2025
Net income (USD)-9.0 M
Diluted EPS (USD/shares)-0.2

Latest filings

FiledFormDescriptionPeriod
2026-09-148-KCURRENT REPORT items 5.072026-09-10
2026-09-018-KCURRENT REPORT items 7.01,8.01,9.012026-09-01
2026-08-1310-QQUARTERLY REPORT2026-06-30
2026-07-28ARSARS2025-12-31
2026-07-28DEFA14ADEFINITIVE ADDITIONAL MATERIALS
2026-07-28DEF 14APROXY STATEMENT2026-09-10
2026-07-24S-8REGISTRATION STATEMENT
2026-07-218-KCURRENT REPORT items 5.022026-07-19
2026-07-178-KCURRENT REPORT items 5.08,8.012026-07-16
2026-05-28442026-05-27
2026-05-288-KCURRENT REPORT items 1.01,3.02,7.01,9.012026-05-27
2026-05-1510-QQUARTERLY REPORT2026-03-31
2026-03-2410-KANNUAL REPORT2025-12-31
2026-02-20442026-02-18
2026-02-05SCHEDULE 13DSCHEDULE 13D
2026-02-02424B4PROSPECTUS
2026-01-29EFFECTEFFECT items ,,
2026-01-293OWNERSHIP DOCUMENT2026-01-29
2026-01-293OWNERSHIP DOCUMENT2026-01-29
2026-01-293OWNERSHIP DOCUMENT2026-01-29
2026-01-293OWNERSHIP DOCUMENT2026-01-29
2026-01-293OWNERSHIP DOCUMENT2026-01-29
2026-01-293OWNERSHIP DOCUMENT2026-01-29
2026-01-293OWNERSHIP DOCUMENT2026-01-29
2026-01-28CERTCERT

Forms on file (last 1,000): 3 7, 8-K 5, 4 2, 10-Q 2, S-1/A 2, C-U 2, ARS 1, DEFA14A 1. Source: SEC EDGAR, as filed; this page is public data and not investment advice.

For software and AI agents: the same data as JSON, per call, no account: GET https://store.agentexchange.work/gw/filings/company?ticker=PLYX (0.002 USD), /gw/filings/filings?ticker=PLYX&form=8-K, /gw/filings/facts?ticker=PLYX&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txt

Updated from EDGAR within 30 minutes of a filing. Agent Exchange